Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Jan;47(1):93–102.

A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis.

J C Homberg, N Stelly, I Andreis, N Abuaf, F Saadoun, J Andre
PMCID: PMC1536357  PMID: 7047027

Abstract

A new immunofluorescence pattern of non-organ- and non-species-specific antibody has been observed in occasional sera. Variations of the fluorescence were found in different species. Recognition of the new pattern was particularly characteristic in rat organs (liver: the hepatocytes showed intense roughly granular fluorescence evenly distributed in the cytoplasm; kidney: the bright fluorescence of the first portion of the proximal tubules contrasted with the negative aspect of the other portions of the tubules; stomach: only some cells probably corresponding to the APUD system were positive; pancreas: fluorescence was limited to the islets of Langherhans). The positivity in the ellipsoid region of the rods and cones of the eye and the absorption on different liver organelles showed that this aspect corresponded to the mitochondria. We propose to name this pattern 'antimitochondria antibody number 6' or 'anti-M6'. High titres of anti-M6 were found in four patients suffering from iproniazid-induced hepatitis. A decrease in the titre was obtained after stopping the treatment. The now exceptional use of iproniazid and the rare occurrence of anti-M6 suggest a link between these two phenomena.

Full text

PDF
93

Images in this article

97Fig. 1
on p.97

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berg P. A., Binder T. Demonstration of mitochondrial antibodies in sera from patients with chronic liver diseases reacting with two different types of complement-fixing antigens. Minerva Gastroenterol. 1976 Jul-Sep;22(3):185–189. [PubMed] [Google Scholar]
  2. Berg P. A. Chronisch-aktive (aggressive) Hepatitis. Zur Differentialdiagnose der lupoiden (ANA-positiven) und cholestatisch verlaufenden (AMA-positiven) Hepatitis. Dtsch Med Wochenschr. 1976 Oct 15;101(42):1536–1543. doi: 10.1055/s-0028-1104369. [DOI] [PubMed] [Google Scholar]
  3. Berg P. A., Doniach D., Roitt I. M. Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J Exp Med. 1967 Aug 1;126(2):277–290. doi: 10.1084/jem.126.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berg P. A., Wiedmann K. H., Sayers T., Klöppel G., Lindner H. Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet. 1980 Dec 20;2(8208-8209):1329–1332. doi: 10.1016/s0140-6736(80)92397-1. [DOI] [PubMed] [Google Scholar]
  5. Bottazzo G. F., Dean B. M., Gorsuch A. N., Cudworth A. G., Doniach D. Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet. 1980 Mar 29;1(8170):668–672. [PubMed] [Google Scholar]
  6. Cartron J. P., Reyes F., Gourdin M. F., Garretta M., Salmon C. H. Antigen site distribution among weak A' red cell populations. A study of A3, Ax and Aend variants. Immunology. 1977 Feb;32(2):233–244. [PMC free article] [PubMed] [Google Scholar]
  7. Cooksley W. G., Cowen A. E., Powell L. W. The incidence of oxyphenisatin ingestion in active chronic hepatitis: a prospective controlled study of 29 patients. Aust N Z J Med. 1973 Apr;3(2):124–128. doi: 10.1111/j.1445-5994.1973.tb03964.x. [DOI] [PubMed] [Google Scholar]
  8. Doniach D., Lindqvist H. L., Berg P. A. Non-organ-specific cytoplasmic antibodies detected by immunofluorescence. Int Arch Allergy Appl Immunol. 1971;41(4):501–513. doi: 10.1159/000230545. [DOI] [PubMed] [Google Scholar]
  9. Grob P. J., Müller-Schoop J. W., Häcki M. A., Joller-Jemelka H. I. Drug-induced pseudolupus. Lancet. 1975 Jul 26;2(7926):144–148. doi: 10.1016/s0140-6736(75)90055-0. [DOI] [PubMed] [Google Scholar]
  10. Homberg J. C. Principaux anticorps antitissus en hépatologie. Données nouvelles et résultats personnels. Med Chir Dig. 1980;9(7):573–577. [PubMed] [Google Scholar]
  11. Homberg J. C., Rizzetto M., Doniach D. Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses. Clin Exp Immunol. 1974 Aug;17(4):617–628. [PMC free article] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Labro M. T., Andrieu M. C., Weber M., Homberg J. C. A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5. Clin Exp Immunol. 1978 Mar;31(3):357–366. [PMC free article] [PubMed] [Google Scholar]
  14. Maas D., Schubothe H. Ein lupus-erythematodes-ähnliches Syndrom mit antimitochondrialen Antikörpern. Dtsch Med Wochenschr. 1973 Jan 26;98(4):131–139. doi: 10.1055/s-0028-1106763. [DOI] [PubMed] [Google Scholar]
  15. Meek F., Khoury E. L., Doniach D., Baum H. Mitochondrial antibodies in chronic liver diseases and connective tissue disorders: further characterization of the autoantigens. Clin Exp Immunol. 1980 Jul;41(1):43–54. [PMC free article] [PubMed] [Google Scholar]
  16. Mitchell J. R., Jollows D. J. Progress in hepatology. Metabolic activation of drugs to toxic substances. Gastroenterology. 1975 Feb;68(2):392–410. [PubMed] [Google Scholar]
  17. Poupon R., Homberg J. C., Abuaf N., Petit J., Bodin F., Darnis F. Atteintes hépatiques dues à l'acide tiénilique. Six observations avec présence d'anticorps antireticulum endoplasmique. Nouv Presse Med. 1980 Jun 21;9(27):1881–1884. [PubMed] [Google Scholar]
  18. Rizzetto M., Swana G., Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973 Nov;15(3):331–344. [PMC free article] [PubMed] [Google Scholar]
  19. Rochant H., Henri A., Tonthat H., Titeux M., Feuilhade F. Expression of the blood group I, i, H, and A1 antigens on erythrocyte membranes studied by immunofluorescence. J Clin Lab Immunol. 1980 Jul;4(1):35–40. [PubMed] [Google Scholar]
  20. STERNBERG W. H., FARBER E., DUNLAP C. E. Histochemical localization of specific oxidative enzymes. II. Localization of diphosphopyridine nucleotide and triphosphopyridine nucleotide diaphorases and the succindehydrogenase system in the kidney. J Histochem Cytochem. 1956 May;4(3):266–283. doi: 10.1177/4.3.266. [DOI] [PubMed] [Google Scholar]
  21. Sottocasa G. L., Kuylenstierna B., Ernster L., Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol. 1967 Feb;32(2):415–438. doi: 10.1083/jcb.32.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. WALKER J. G., DONIACH D., ROITT I. M., SHERLOCK S. SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet. 1965 Apr 17;1(7390):827–831. doi: 10.1016/s0140-6736(65)91372-3. [DOI] [PubMed] [Google Scholar]
  23. WELLER T. H., COONS A. H. Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):789–794. doi: 10.3181/00379727-86-21235. [DOI] [PubMed] [Google Scholar]
  24. Walton B., Simpson B. R., Strunin L., Doniach D., Perrin J., Appleyard A. J. Unexplained hepatitis following halothane. Br Med J. 1976 May 15;1(6019):1171–1176. doi: 10.1136/bmj.1.6019.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wright D. J., Doniach D., Lessof M. H., Turk J. L., Grimble A. S., Catterall R. D. New antibody in early syphilis. Lancet. 1970 Apr 11;1(7650):740–743. doi: 10.1016/s0140-6736(70)90972-4. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES